152 related articles for article (PubMed ID: 32442081)
21. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
23. Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation.
Emir S; Karakurt N; Karakuş E; Şenel E; Kırsaçlıoğlu C; Demir HA; Orhan D
Turk J Pediatr; 2014; 56(1):88-91. PubMed ID: 24827954
[TBL] [Abstract][Full Text] [Related]
24. Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.
Kang GH; Kim YI
Virchows Arch; 1998 Jan; 432(1):85-7. PubMed ID: 9463592
[TBL] [Abstract][Full Text] [Related]
25. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
Nuevo-Gonzalez JA; Cano-Ballesteros JC; Lopez B; Andueza-Lillo JA; Audibert L
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S28-31. PubMed ID: 21826411
[TBL] [Abstract][Full Text] [Related]
26. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
27. Hepatoid carcinoma of the stomach.
deLorimier A; Park F; Aranha GV; Reyes C
Cancer; 1993 Jan; 71(2):293-6. PubMed ID: 7678544
[TBL] [Abstract][Full Text] [Related]
28. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
[TBL] [Abstract][Full Text] [Related]
29. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
30. Different characteristics of hepatoid and non-hepatoid alpha-fetoprotein-producing gastric carcinomas: an experimental study using xenografted tumors.
Aizawa K; Motoyama T; Suzuki S; Tanaka N; Yabusaki H; Tanaka S; Muto I; Tanaka O; Hatakeyama K
Int J Cancer; 1994 Aug; 58(3):430-5. PubMed ID: 7519587
[TBL] [Abstract][Full Text] [Related]
31. Hepatoid adenocarcinoma of the stomach.
Inagawa S; Shimazaki J; Hori M; Yoshimi F; Adachi S; Kawamoto T; Fukao K; Itabashi M
Gastric Cancer; 2001; 4(1):43-52. PubMed ID: 11706627
[TBL] [Abstract][Full Text] [Related]
32. Hepatoid gastric adenocarcinoma.
Matias-Guiu X; Guix M
Pathol Res Pract; 1989 Sep; 185(3):397-400; discussion 400-4. PubMed ID: 2554265
[TBL] [Abstract][Full Text] [Related]
33. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
34. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
35. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
[TBL] [Abstract][Full Text] [Related]
36. [Hepatoid carcinoma of the ovary: report of a case].
Chen H; Li XF; Li XM
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):622-624. PubMed ID: 38825912
[TBL] [Abstract][Full Text] [Related]
37. LRP16 prevents hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
Shao L; Jing W; Wang L; Pan F; Wu L; Zhang L; Yang P; Hu M; Fan K
J Mol Med (Berl); 2018 Jun; 96(6):547-558. PubMed ID: 29748698
[TBL] [Abstract][Full Text] [Related]
38. [A case of hepatic metastasis of gastric hepatoid adenocarcinoma mistaken for primary hepatocellular carcinoma].
Moon JY; Kim GH; Cheong JH; Lee BE; Ryu DY; Song GA
Korean J Gastroenterol; 2012 Oct; 60(4):262-6. PubMed ID: 23089914
[TBL] [Abstract][Full Text] [Related]
39. Detection of β-catenin, gastrokine-2 and embryonic stem cell expressed ras in gastric cancers.
Zhang F; Tang JM; Wang L; Shen JY; Zheng L; Wu PP; Zhang M; Yan ZW
Int J Clin Exp Pathol; 2010 Nov; 3(8):782-91. PubMed ID: 21151392
[TBL] [Abstract][Full Text] [Related]
40. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
